依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AEZS 依特钠

盘前交易 11-06 04:22:20 EST

5.72

+0.00

0.00%

最高5.72	最低5.72	成交量0.00
今开5.72	昨收5.72	日振幅0.00%
总市值2,114万	流通市值1,625万	总股本369.52万
成交额4.31万	换手率0.00%	流通股本284.02万
市净率1.63	ROE-81.71%	每股收益-14.86
52周最高12.00	52周最低3.96	市盈率-0.38
股息0.00	股息收益率0.00	ROA-29.96%

北京优虎网络科技有限公司

{"stockData":{"symbol":"AEZS","market":"US","secType":"STK","nameCN":"依特钠","latestPrice":5.72,"timestamp":1723147200000,"preClose":5.72,"halted":8,"volume":0,"delay":0,"floatShares":2840200,"shares":3695230,"eps":-14.863927,"marketStatus":"盘前交易","change":0,"latestTime":"11-06 04:22:16 EST","open":5.72,"high":5.72,"low":5.72,"amount":43107.4179888,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.863927,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762439400000},"marketStatusCode":1,"symbolChange":{"newSymbol":"CSCI","executeDate":"2024-08-09"},"adr":0,"adrRate":0,"listingDate":957931200000,"exchange":"NASDAQ","adjPreClose":5.72,"volumeRatio":0},"requestUrl":"/m/hq/s/AEZS","defaultTab":"news","newsList":[{"id":"2458105323","title":"依特钠盘中异动 下午盘股价大涨8.52%报5.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458105323","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458105323?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:32","pubTimestamp":1723141926,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时32分，依特钠股票出现异动，股价大幅拉升8.52%。截至发稿，该股报5.86美元/股，成交量2672股，换手率0.09%，振幅1.11%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为3.81%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023206968253bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023206968253bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS","CSCI"],"gpt_icon":0},{"id":"2457828994","title":"依特钠盘中异动 早盘快速上涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457828994","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457828994?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:51","pubTimestamp":1723042269,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时51分，依特钠股票出现异动，股价急速拉升5.73%。截至发稿，该股报5.74美元/股，成交量3700股，换手率0.12%，振幅2.95%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为1.31%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807225109aefdbc68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807225109aefdbc68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2457776245","title":"依特钠盘中异动 大幅下跌12.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457776245","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457776245?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:04","pubTimestamp":1722866643,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日22时04分，依特钠股票出现波动，股价快速下挫12.84%。截至发稿，该股报5.16美元/股，成交量2099股，换手率0.07%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为1.93%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522040396823f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522040396823f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2456591251","title":"依特钠盘中异动 股价大跌5.87%报5.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456591251","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456591251?lang=zh_cn&edition=full","pubTime":"2024-08-03 02:36","pubTimestamp":1722623802,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日02时36分，依特钠股票出现异动，股价急速下跌5.87%。截至发稿，该股报5.62美元/股，成交量648股，换手率0.02%，振幅0.70%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-5.75百万美元，每股收益-18.95美元，毛利-56000.00美元，市盈率-2.44倍。依特钠股票所在的生物技术行业中，整体跌幅为1.65%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803023642af95abdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803023642af95abdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2456439051","title":"依特钠盘中异动 早盘急速拉升6.90%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456439051","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456439051?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:34","pubTimestamp":1722522892,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时34分，依特钠股票出现异动，股价急速上涨6.90%。截至发稿，该股报6.20美元/股，成交量1724股，换手率0.06%，振幅2.76%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.36%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223453941fd066&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223453941fd066&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2455663742","title":"依特钠盘中异动 股价大涨7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663742","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663742?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:40","pubTimestamp":1722260408,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时40分，依特钠股票出现波动，股价急速拉升7.10%。截至发稿，该股报5.73美元/股，成交量3645股，换手率0.12%，振幅7.48%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.32%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729214008941fb874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729214008941fb874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2453793029","title":"依特钠盘中异动 早盘急速跳水8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793029","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453793029?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:43","pubTimestamp":1721655821,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时43分，依特钠股票出现异动，股价大幅下跌8.21%。截至发稿，该股报5.37美元/股，成交量79股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.65%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222143429681ee59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222143429681ee59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2451804628","title":"依特钠盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451804628","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451804628?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:32","pubTimestamp":1721050350,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时32分，依特钠股票出现异动，股价快速下跌5.04%。截至发稿，该股报6.00美元/股，成交量296股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.18%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132319f4f23a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132319f4f23a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2450533290","title":"依特钠盘中异动 股价大跌7.75%报6.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450533290","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450533290?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:35","pubTimestamp":1720791343,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时35分，依特钠股票出现波动，股价大幅下跌7.75%。截至发稿，该股报6.31美元/股，成交量475股，换手率0.02%，振幅0.00%。依特钠股票所在的生物技术行业中，整体涨幅为0.58%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213544af921ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213544af921ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2450690663","title":"依特钠盘中异动 早盘快速跳水5.64%报6.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450690663","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450690663?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:40","pubTimestamp":1720708813,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时40分，依特钠股票出现异动，股价快速下跌5.64%。截至发稿，该股报6.52美元/股，成交量5769股，换手率0.19%，振幅7.53%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.74%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711224014941f64e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711224014941f64e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2450813803","title":"依特钠盘中异动 大幅拉升5.65%报7.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813803","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450813803?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:34","pubTimestamp":1720618466,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时34分，依特钠股票出现波动，股价急速拉升5.65%。截至发稿，该股报7.27美元/股，成交量3178股，换手率0.10%，振幅2.47%。依特钠股票所在的生物技术行业中，整体涨幅为0.15%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213426aef8fc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213426aef8fc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2450026865","title":"依特钠盘中异动 早盘急速上涨13.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450026865","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450026865?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:09","pubTimestamp":1720534198,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时09分，依特钠股票出现异动，股价大幅上涨13.24%。截至发稿，该股报5.95美元/股，成交量2897股，换手率0.09%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为1.05%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220958941f571d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220958941f571d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2449094017","title":"依特钠盘中异动 股价大涨8.42%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449094017","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449094017?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:28","pubTimestamp":1720448898,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时28分，依特钠股票出现异动，股价大幅上涨8.42%。截至发稿，该股报5.15美元/股，成交量960股，换手率0.03%，振幅2.75%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.83%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222819941f4f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222819941f4f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2448164166","title":"依特钠盘中异动 早盘股价大跌5.96%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448164166","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448164166?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:25","pubTimestamp":1719933957,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时25分，依特钠股票出现波动，股价急速下跌5.96%。截至发稿，该股报4.42美元/股，成交量461股，换手率0.02%，振幅3.43%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.86%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702232557aef79bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702232557aef79bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2448916967","title":"依特钠盘中异动 早盘股价大涨9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448916967","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448916967?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:17","pubTimestamp":1719843464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时17分，依特钠股票出现异动，股价急速上涨9.16%。截至发稿，该股报4.83美元/股，成交量332股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.78%。依特钠的主导产品之一是 macimorelin ，这是美国 FDA 和欧盟委员会批准的第一个也是唯一一个用于诊断成人生长激素缺乏症  的口服检测试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221744aef76ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221744aef76ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2445009839","title":"依特钠盘中异动 早盘急速拉升5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445009839","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445009839?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:23","pubTimestamp":1719242625,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日23时23分，依特钠股票出现异动，股价快速拉升5.51%。截至发稿，该股报4.84美元/股，成交量4882股，换手率0.40%，振幅4.69%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为1.86%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242323469681647f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242323469681647f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2445750084","title":"依特钠盘中异动 早盘股价大涨5.51%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445750084","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445750084?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:31","pubTimestamp":1718976664,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时31分，依特钠股票出现波动，股价大幅拉升5.51%。截至发稿，该股报4.87美元/股，成交量717股，换手率0.06%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.27%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213104941f01e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213104941f01e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEZS","BK4139"],"gpt_icon":0},{"id":"2444214905","title":"依特钠盘中异动 快速下跌7.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444214905","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444214905?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890294,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分，依特钠股票出现异动，股价大幅跳水7.59%。截至发稿，该股报5.60美元/股，成交量73股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体涨幅为0.13%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213134941efd37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213134941efd37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2444944011","title":"依特钠盘中异动 股价大跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444944011","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444944011?lang=zh_cn&edition=full","pubTime":"2024-06-18 00:25","pubTimestamp":1718641531,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日00时25分，依特钠股票出现波动，股价急速下跌6.90%。截至发稿，该股报6.00美元/股，成交量3264股，换手率0.27%，振幅2.02%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.56%。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061800253196814ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061800253196814ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0},{"id":"2442127853","title":"依特钠盘中异动 大幅跳水5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442127853","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442127853?lang=zh_cn&edition=full","pubTime":"2024-06-12 01:29","pubTimestamp":1718126982,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日01时29分，依特钠股票出现异动，股价大幅跳水5.62%。截至发稿，该股报6.89美元/股，成交量3751股，换手率0.31%，振幅3.70%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。依特钠股票所在的生物技术行业中，整体跌幅为0.34%。依特钠公司简介：AEterna Zentaris Inc 是一家致力于商业化和开发治疗和诊断测试的生物制药公司。它正在利用 macimorelin 的临床成功和安全性来开发用于诊断儿童发病的 GHD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612012943aef45f50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612012943aef45f50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AEZS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentaris.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":0.0089},{"period":"3month","weight":0.0717},{"period":"6month","weight":0.2007},{"period":"1year","weight":0.1749},{"period":"ytd","weight":0.1561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aeterna Zentaris, Inc.于1990年9月12日 ，在Canada Business Corporations Act名下成立，并继续受其管理。Aeterna Zentaris是一家晚期药物的开发公司，专业从事肿瘤学和内分泌治疗。公司产品线包括从开发到销售所有阶段的化合物。公司的主要业务战略是与战略合作伙伴共同进步，其产品开发线上的重点候选产品主要用于肿瘤学和内分泌学领域。此外，该公司还继续推进其他临床和临床前程序，其中一些通过了不同政府机构的授权。公司的愿景是成为一个综合的专业生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.049213},{"month":2,"riseRate":0.458333,"avgChangeRate":0.00928},{"month":3,"riseRate":0.458333,"avgChangeRate":-0.011313},{"month":4,"riseRate":0.541667,"avgChangeRate":0.065619},{"month":5,"riseRate":0.5,"avgChangeRate":0.042204},{"month":6,"riseRate":0.24,"avgChangeRate":-0.097582},{"month":7,"riseRate":0.32,"avgChangeRate":-0.026907},{"month":8,"riseRate":0.48,"avgChangeRate":-0.038784},{"month":9,"riseRate":0.291667,"avgChangeRate":-0.061538},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.046147},{"month":11,"riseRate":0.5,"avgChangeRate":0.058342},{"month":12,"riseRate":0.5,"avgChangeRate":-0.01243}],"exchange":"NASDAQ","name":"依特钠","nameEN":"AEterna Zentaris"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"依特钠,AEZS,依特钠股票,依特钠股票老虎,依特钠股票老虎国际,依特钠行情,依特钠股票行情,依特钠股价,依特钠股市,依特钠股票价格,依特钠股票交易,依特钠股票购买,依特钠股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"依特钠(AEZS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供依特钠(AEZS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}